A Pilot Study Demonstrating Clinical Benefit From Intralesional Interferon Alpha 2B in the Treatment of Peyronie's Disease
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Intralesional therapy is a less invasive method for the treatment of Peyronie's disease. The objective of this study was to evaluate intralesional injections of interferon alpha 2B (IFN‐α‐2B) as an effective alternative to the surgical treatment of Peyronie's disease. Twenty‐one patients with Peyronie's disease were evaluated by use of penile duplex Doppler ultrasonography for cavernosal blood flows, degree of penile curvature, and plaque size. A questionnaire was given to all patients to assess sexual function. Each patient then received biweekly intralesional injections of 1 × 10 6 units of IFN‐α‐2B in 10 ml of normal saline over a period of 6 months. There was no placebo control group in this study. At the conclusion of the study, penile duplex Doppler imaging was repeated. A questionnaire was completed by all patients to assess changes in sexufunction after treatment. Twenty patients completed the study, with all men reporting subjective softening of their plaques. Nine of 10 patients initially reporting penile pain with erection (90%) had resolution of their phallalgia while on study protocol. Thirteen patients (65%) had significant improvement in curvature, ranging from 20 to 90%. Seventeen patients (85%) demonstrated an objective 10 to 80% decrease in plaque size. Biweekly intralesional injections of Peyronie's plaques with IFN‐α‐2B resulted in a significant improvement in penile curvature, diminished pain, and reduced plaque size, and resulted in a subjective improvement in sexual function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
El-Sakka, A. I., Hassoba, H. M., Pillarisetty, R. J., Dahiya, R., & Lue, T. F. (1997) · Journal of Urology · doi:10.1016/s0022-5347(01)64223-x · Cited by 250
Duncan, M. R., Berman, B., & Nseyo, U. O. (1991) · Scandinavian Journal of Urology and Nephrology · doi:10.3109/00365599109024539 · Cited by 132
Chromosome Abnormalities in Peyronie’s Disease
Somers, K. D., Winters, B. A., Dawson, D. M., Leffell, M. S., Wright, G. L., Devine, C. J., Gilbert, D. A., & Horton, C. E. (1987) · Journal of Urology · doi:10.1016/s0022-5347(17)44170-x · Cited by 76
GENTILE, V., MODESTI, A., LA PERA, G., VASATURO, F., MODICA, A., PRIGIOTTI, G., DI SILVERIO, F., & SCARPA, S. (1996) · Journal of Andrology · doi:10.1002/j.1939-4640.1996.tb01757.x · Cited by 35
Cited by
Evidence-Based Management Guidelines on Peyronie's Disease
Chung, E., Ralph, D., Kagioglu, A., Garaffa, G., Shamsodini, A., Bivalacqua, T., Glina, S., Hakim, L., Sadeghi-Nejad, H., & Broderick, G. (2016) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2016.04.062 · Cited by 227
Self-citationHellstrom, W. J. G., Kendirci, M., Matern, R., Cockerham, Y., Myers, L., Sikka, S. C., Venable, D., Honig, S., McCullough, A., Hakim, L. S., et al. (2006) · Journal of Urology · doi:10.1016/s0022-5347(06)00517-9 · Cited by 223
Self-citationPeyronie's Disease: Etiology, Medical, and Surgical Therapy
HELLSTROM, W. J. G., & BIVALACQUA, T. J. (2000) · Journal of Andrology · doi:10.1002/j.1939-4640.2000.tb03387.x · Cited by 170
Self-citationPeyronie’s disease: Contemporary evaluation and management
Ziegelmann, M. J., Bajic, P., & Levine, L. A. (2020) · International Journal of Urology · doi:10.1111/iju.14230 · Cited by 86
Gene expression in Peyronie's disease
Gonzalez-Cadavid, N. F., Magee, T. R., Ferrini, M., Qian, A., Vernet, D., & Rajfer, J. (2002) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3900873 · Cited by 84
Metadata
- Authors
- AHUJA, S., BIVALACQUA, T. J., CASE, J., VINCENT, M., SJXKA, S. C., & HELLSTROM, W. J. G.
- Venue
- Journal of Andrology
- Publisher
- Wiley
- Published
- 1999-07-08
- Volume
- 20
- Issue
- 4
- Pages
- 444-448
- ISSN
- 0196-3635 (ISSN-L)
- 1939-4640
- OpenAlex
- W1570494766
- Cited by
- 60
- References
- 4
- FWCI
- 2.19
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Pilot Study Demonstrating Clinical Benefit From Intralesional Interferon Alpha 2B in the Treatment of Peyronie's Disease. https://app.cochat.ai/papers/10.1002/j.1939-4640.1999.tb02539.x
- The paper
- AHUJA, S., BIVALACQUA, T. J., CASE, J., VINCENT, M., SJXKA, S. C., & HELLSTROM, W. J. G. (1999). A Pilot Study Demonstrating Clinical Benefit From Intralesional Interferon Alpha 2B in the Treatment of Peyronie's Disease. Journal of Andrology. https://doi.org/10.1002/j.1939-4640.1999.tb02539.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.